Seeta Ram Anjaneyulu Gorantla

Seeta Ram Anjaneyulu Gorantla

Active Director Director DIN 01874325
DIN 01874325 First appointment Aug 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 3 historical roles
Total affiliations 4 Since Aug 2008
Shareholding value •••• Premium profile

About Seeta Ram Anjaneyulu Gorantla

Data last updated:

Seeta Ram Anjaneyulu Gorantla is a Director at Sai Parenteral's Limited (since 2024). The companies operate in Pharma and Real Estate and Construction. Sai Parenteral's Limited reported revenue of ₹164 Cr (FY 2025). Earlier, Seeta Ram Anjaneyulu Gorantla was a Director at Phyto Chem (India) Limited (2017–2025) and Director at Talli Godavari Fine Chemicals Private Limited (2008–2013) and 1 more.

DIN 01874325
Primary Designation Director
Industry Pharma
First Appointment 23 Aug 2008
Oldest Company Age 25 yrs
Largest company Sai Parenteral's Limited · ₹164 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sai Parenteral's Limited U24231TG2001PLC036043
Director01 Jan 20242001₹164 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Phyto Chem (India) Limited L24110TG1989PLC009500
Director26 Aug 20171989₹16.55 Cr (FY 2025)Active
Director23 Aug 20081997Active
Sriam Labs Private Limited U24239AP2002PTC121365
Director25 Jul 20142002₹77.88 Cr (FY 2026)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Seeta Ram Anjaneyulu Gorantla

NameDINCompanyDesignation
Anil KumarSai Parenteral's LimitedCfo
Anil Kumar Karusala01866646Sai Parenteral's LimitedManaging Director
Aruna Karusala01673731Sai Parenteral's LimitedDirector
Bhagyashri Dharmasa Zad09174356Sai Parenteral's LimitedDirector
Kalidindi Venkateswara Raju00788664Sai Parenteral's LimitedDirector
Shivali AggarwalSai Parenteral's LimitedCompany Secretary
Venkoji Prakash Babu DamarlaSai Parenteral's LimitedCeo
Vijitha Gorrepati03492979Sai Parenteral's LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Sai Parenteral's Limited
Phyto Chem (India) Limited
Talli Godavari Fine Chemicals Private Limited
Sriam Labs Private Limited
Premium access

Shareholding and investment profile for Seeta Ram Anjaneyulu Gorantla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seeta Ram Anjaneyulu Gorantla

Seeta Ram Anjaneyulu Gorantla currently holds 1 directorship: Sai Parenteral's Limited (Director, since 01 Jan 2024, revenue ₹164 Cr (FY 2025)).

Seeta Ram Anjaneyulu Gorantla was first appointed on 23 Aug 2008 as Director at Talli Godavari Fine Chemicals Private Limited. The most recent appointment on record is 01 Jan 2024 at Sai Parenteral's Limited.

Seeta Ram Anjaneyulu Gorantla held 3 earlier board appointments: Phyto Chem (India) Limited (Director, 26 Aug 2017 to 29 Sep 2025); Talli Godavari Fine Chemicals Private Limited (Director, 23 Aug 2008 to 04 Nov 2013); Sriam Labs Private Limited (Director, 25 Jul 2014 to 08 Jul 2019).

The current boards of Seeta Ram Anjaneyulu Gorantla's companies include Anil Kumar (Sai Parenteral's Limited), Anil Kumar Karusala (Sai Parenteral's Limited), Aruna Karusala (Sai Parenteral's Limited), Bhagyashri Dharmasa Zad (Sai Parenteral's Limited), Kalidindi Venkateswara Raju (Sai Parenteral's Limited), Shivali Aggarwal (Sai Parenteral's Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available